首页> 外文期刊>Diabetes >A Point Mutation Inactivating the Sulfonylurea Receptor Causes the Severe Form of Persistent Hyperinsulinemic Hypoglycemia of Infancy in Finland
【24h】

A Point Mutation Inactivating the Sulfonylurea Receptor Causes the Severe Form of Persistent Hyperinsulinemic Hypoglycemia of Infancy in Finland

机译:点突变使磺酰脲受体失活导致芬兰婴儿持续性高胰岛素低血糖的严重形式

获取原文
获取原文并翻译 | 示例
       

摘要

Mutations in genes encoding the ATP-regulated potas- sium (K_ATP) channels of the pancreatic β-cell (SUR1 and Kir6.2) are the major known cause of persistent hyperinsulinemic hypoglycemia of infancy (PHHI). We collected all cases of PHHI diagnosed in Finland between 1983 and 1997 (n=24). The overall incidence was 1:40, 400, but in one area of Central Finland it was as high as 1:3, 200. Haplotype analysis using polymorphic markers spanning the SUR1/Kir6.2 gene cluster con- firmed linkage to the 11p region. Sequence analysis revealed a novel point mutation in exon 4 of SUR1, pre- dicting a valine to aspartic acid change at amino acid 187 (V187D).
机译:婴儿持续高胰岛素血症性低血糖症(PHHI)的主要已知病因是编码胰岛β细胞ATP调节钾(K_ATP)通道(SUR1和Kir6.2)的基因突变。我们收集了1983年至1997年之间在芬兰诊断出的所有PHHI病例(n = 24)。总体发生率为1:40,400,但在芬兰中部的一个地区则高达1:3,200。使用跨越SUR1 / Kir6.2基因簇的多态性标记进行单倍型分析可确保与11p区的连锁。序列分析揭示了SUR1外显子4中有一个新的点突变,预测缬氨酸在187位氨基酸(V187D)上会向天冬氨酸变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号